MultiCell Technologies, Inc. has added Scott Lukeman, Ph.D., to its board of directors. He has over 25 years of international experience across multiple life-science disciplines in management, strategic planning, business and technology valuation and development, marketing, licensing, fund-raising and competitive intelligence.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -90.00% | 0.00% | 0.00% |
2015 | MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt | CI |
2014 | MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 5K | |
+18.15% | 47.02B | |
+48.77% | 41.86B | |
+0.99% | 41.76B | |
-4.27% | 28.8B | |
+11.40% | 26.05B | |
-21.29% | 19.15B | |
+4.80% | 12.55B | |
+27.47% | 12.34B | |
-3.78% | 11.82B |
- Stock Market
- Equities
- MCET Stock
- News MultiCell Technologies, Inc.
- MultiCell Technologies, Inc. Adds Scott Lukeman to its Board of Directors